Atlas Trials

Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy

Clinical trial NCT03113422 · COMPLETED

Trial details

NCT number
NCT03113422
Sponsor
PrECOG, LLC.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Follicular LymphomaNon-Hodgkin's Lymphoma FollicularNon-Hodgkin's Lymphoma, Adult High Grade
Start date
2017-12-27
Primary completion
2021-05-03
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.